Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-008933
Filing Date
2017-05-12
Accepted
2017-05-12 16:20:31
Documents
46
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kool20170331_10q.htm 10-Q 657438
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10241
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10069
4 EXHIBIT 32 ex32.htm EX-32 7814
  Complete submission text file 0001437749-17-008933.txt   3425540

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS kool-20170331.xml EX-101.INS 506544
6 EXHIBIT 101.SCH kool-20170331.xsd EX-101.SCH 37786
7 EXHIBIT 101.CAL kool-20170331_cal.xml EX-101.CAL 38019
8 EXHIBIT 101.DEF kool-20170331_def.xml EX-101.DEF 294086
9 EXHIBIT 101.LAB kool-20170331_lab.xml EX-101.LAB 293440
10 EXHIBIT 101.PRE kool-20170331_pre.xml EX-101.PRE 310677
Mailing Address 2711 CITRUS ROAD RANCHO CORDOVA CA 95742
Business Address 2711 CITRUS ROAD RANCHO CORDOVA CA 95742 9168585100
CESCA THERAPEUTICS INC. (Filer) CIK: 0000811212 (see all company filings)

IRS No.: 943018487 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-82900 | Film No.: 17838919
SIC: 3821 Laboratory Apparatus & Furniture